DailyMed hydroquinone 4%- hydroquinone cream
Uno studio dellUniversit di Oxford pubblicato sul BMJ che ha analizzato i dati di oltre 9.000 pazienti da 37 studi clinici ha stimato che i benefici cardiometabolici scompaiono in media entro circa 18 mesi dalla sospensione senza interventi di mantenimento
Deanfield J et al
He has also received grants from Medical Research Council, European Union, JPND, Alzheimers Research, UK, Alzheimers Drug Discovery Foundation, Alzheimers Society, UK, Alzheimers Association, US, Medical P.E
While findings suggest multiple areas of research relevance, further study is required to clarify its mechanisms and applications
The rising incidence of T2DM globally has further boosted the adoption of GLP-1 receptor agonists, especially as healthcare providers increasingly recommend these drugs due to their unique therapeutic benefits